| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |